Bausch + Lomb

Study Finds XIIDRA May Improve Comfort for Symptomatic Contact Lens Wearers

Results from a new investigator-initiated study suggest that XIIDRA® (lifitegrast ophthalmic solution 5%), a prescription drop approved for dry eye...

Read More
Bausch + Lomb

Bausch + Lomb Combines Patient Voices and New Survey Insights to Combat Persistent Misconceptions about Dry Eye

Bausch + Lomb Corporation today launched “Eyes Tell the Story: The Impact of Dry Eye” The campaign aims to educate about dry eye through...

Read More
Bausch + Lomb

B + L Announces Publication of Phase 4 Data on the Early Effects of MIEBO® on Patient-Reported Outcomes in Dry Eye Disease in Ophthalmology and Therapy Journal

Bausch + Lomb Corporation announced Ophthalmology and Therapy has published results from a phase 4 study which assessed early patient-reported...

Read More
The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc. logos

CEVR and SCOPE Health Sign a MoU to Develop and Commercialize Novel Product Technologies for the Treatment of Dry Eye and Ocular Surface Conditions

The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc have announced the signing of a Memorandum of Understanding (MoU) to...

Read More
Bausch + Lomb

Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief

Bausch + Lomb Corporation shared results from the company’s inaugural State of Dry Eye survey, which explores dry eye understanding and...

Read More